表紙:心臓バイオインプラントデバイスの世界市場、規模、市場予測(2022年~2027年)、業界動向、成長、洞察、COVID-19の影響、企業分析
市場調査レポート
商品コード
1066779

心臓バイオインプラントデバイスの世界市場、規模、市場予測(2022年~2027年)、業界動向、成長、洞察、COVID-19の影響、企業分析

Cardiac Bio Implant Devices Market, Size, Global Forecast 2022-2027, Industry Trends, Growth, Insight, Impact of COVID-19, Company Analysis

出版日: | 発行: Renub Research | ページ情報: 英文 135 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=136.22円
心臓バイオインプラントデバイスの世界市場、規模、市場予測(2022年~2027年)、業界動向、成長、洞察、COVID-19の影響、企業分析
出版日: 2022年03月01日
発行: Renub Research
ページ情報: 英文 135 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の心臓バイオインプラントデバイスの市場規模は、2021年に312億9,000万米ドルとなりました。同市場は、2021年~2028年にかけて7.3%のCAGRで拡大し、2028年に512億米ドルに達すると予測されています。

心血管障害の蔓延と認知度の向上が、世界の心臓バイオインプラントデバイス市場を牽引しています。

当レポートでは、世界の心臓バイオインプラントデバイス市場について調査し、市場の概要とともに、タイプ別、用途別、エンドユーザー別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場力学

  • 成長要因
  • 課題

第5章 心臓バイオインプラントデバイス市場

第6章 市場シェア-心臓バイオインプラントデバイス市場

  • タイプ別
  • 用途別
  • エンドユーザー別
  • 地域別

第7章 心臓バイオインプラントデバイス市場、タイプ別

  • ペースメーカー
  • ICD(植込み型除細動器)
  • CRT(心臓再同期療法)

第8章 心臓バイオインプラントデバイス市場、用途別

  • 不整脈
  • 心筋虚血
  • 急性心筋梗塞
  • 心不全

第9章 心臓バイオインプラントデバイス市場、エンドユーザー別

  • 病院
  • 心臓ケアセンター
  • 外来センターと在宅ケア
  • 学術機関
  • その他

第10章 心臓バイオインプラントデバイス市場、地域別

  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第11章 ポーターのファイブフォース

  • 概要
  • 買い手の交渉力
  • 売り手の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第12章 企業分析

  • Agilent Technologies
  • Eurofins Scientific
  • F. Hoffman-La Roche
  • Illumina, Inc.
  • Natera, Inc.
  • PerkinElmer Inc.
  • Quest Diagnostics
  • Thermo Fisher Scientific
図表

List of Figures

  • Figure-01: Global - Cardiac Bio Implant Devices Market (Billion US$), 2018 - 2021
  • Figure-02: Global - Forecast for Cardiac Bio Implant Devices Market (Billion US$), 2022 - 2027
  • Figure-03: Type - Pacemaker Market (Billion US$), 2018 - 2021
  • Figure-04: Type - Forecast for Pacemaker Market (Billion US$), 2022 - 2027
  • Figure-05: Type - ICDs (Implantable Cardioverter Defibrillator) Market (Billion US$), 2018 - 2021
  • Figure-06: Type - Forecast for ICDs (Implantable Cardioverter Defibrillator) Market (Billion US$), 2022 - 2027
  • Figure-07: Type - CRT (Cardiac Resynchronization Therapy) Market (Billion US$), 2018 - 2021
  • Figure-08: Type - Forecast for CRT (Cardiac Resynchronization Therapy) Market (Billion US$), 2022 - 2027
  • Figure-09: Application - Arrhythmias Market (Million US$), 2018 - 2021
  • Figure-10: Application - Forecast for Arrhythmias Market (Million US$), 2022 - 2027
  • Figure-11: Application - Myocardial Ischemia Market (Billion US$), 2018 - 2021
  • Figure-12: Application - Forecast for Myocardial Ischemia Market (Billion US$), 2022 - 2027
  • Figure-13: Application - Acute Myocardial Infarction Market (Billion US$), 2018 - 2021
  • Figure-14: Application - Forecast for Acute Myocardial Infarction Market (Billion US$), 2022 - 2027
  • Figure-15: Application - Heart Failure Market (Billion US$), 2018 - 2021
  • Figure-16: Application - Forecast for Heart Failure Market (Billion US$), 2022 - 2027
  • Figure-17: End-User - Hospitals Market (Billion US$), 2018 - 2021
  • Figure-18: End-User - Forecast for Hospitals Market (Billion US$), 2022 - 2027
  • Figure-19: End-User - Cardiac Care Centers Market (Billion US$), 2018 - 2021
  • Figure-20: End-User - Forecast for Cardiac Care Centers Market (Billion US$), 2022 - 2027
  • Figure-21: End-User - Ambulatory Centers & Home Care Market (Billion US$), 2018 - 2021
  • Figure-22: End-User - Forecast for Ambulatory Centers & Home Care Market (Billion US$), 2022 - 2027
  • Figure-23: End-User - Academic Institutes Market (Billion US$), 2018 - 2021
  • Figure-24: End-User - Forecast for Academic Institutes Market (Billion US$), 2022 - 2027
  • Figure-25: End-User - Others Market (Billion US$), 2018 - 2021
  • Figure-26: End-User - Forecast for Others Market (Billion US$), 2022 - 2027
  • Figure-27: North America - Cardiac Bio Implant Devices Market (Billion US$), 2018 - 2021
  • Figure-28: North America - Forecast for Cardiac Bio Implant Devices Market (Billion US$), 2022 - 2027
  • Figure-29: Europe - Cardiac Bio Implant Devices Market (Billion US$), 2018 - 2021
  • Figure-30: Europe - Forecast for Cardiac Bio Implant Devices Market (Billion US$), 2022 - 2027
  • Figure-31: Asia-Pacific - Cardiac Bio Implant Devices Market (Billion US$), 2018 - 2021
  • Figure-32: Asia-Pacific - Forecast for Cardiac Bio Implant Devices Market (Billion US$), 2022 - 2027
  • Figure-33: Latin America - Cardiac Bio Implant Devices Market (Million US$), 2018 - 2021
  • Figure-34: Latin America - Forecast for Cardiac Bio Implant Devices Market (Million US$), 2022 - 2027
  • Figure-35: Middle East and Africa - Cardiac Bio Implant Devices Market (Million US$), 2018 - 2021
  • Figure-36: Middle East and Africa - Forecast for Cardiac Bio Implant Devices Market (Million US$), 2022 - 2027
  • Figure-37: Agilent Technologies - Global Revenue (Billion US$), 2018 - 2021
  • Figure-38: Agilent Technologies - Forecast for Global Revenue (Billion US$), 2022 - 2027
  • Figure-39: Eurofins Scientific - Global Revenue (Billion US$), 2018 - 2021
  • Figure-40: Eurofins Scientific - Forecast for Global Revenue (Billion US$), 2022 - 2027
  • Figure-41: F. Hoffman-La Roche - Global Revenue (Billion US$), 2018 - 2021
  • Figure-42: F. Hoffman-La Roche - Forecast for Global Revenue (Billion US$), 2022 - 2027
  • Figure-43: Illumina, Inc. - Global Revenue (Billion US$), 2018 - 2021
  • Figure-44: Illumina, Inc. - Forecast for Global Revenue (Billion US$), 2022 - 2027
  • Figure-45: Natera, Inc. - Global Revenue (Million US$), 2018 - 2021
  • Figure-46: Natera, Inc. - Forecast for Global Revenue (Million US$), 2022 - 2027
  • Figure-47: PerkinElmer Inc. - Global Revenue (Billion US$), 2018 - 2021
  • Figure-48: PerkinElmer Inc. - Forecast for Global Revenue (Billion US$), 2022 - 2027
  • Figure-49: Quest Diagnostics - Global Revenue (Billion US$), 2018 - 2021
  • Figure-50: Quest Diagnostics - Forecast for Global Revenue (Billion US$), 2022 - 2027
  • Figure-51: Thermo Fisher Scientific - Global Revenue (Billion US$), 2018 - 2021
  • Figure-52: Thermo Fisher Scientific - Forecast for Global Revenue (Billion US$), 2022 - 2027

List of Tables

  • Table-01: Global - Cardiac Bio Implant Devices Market Share by Type (Percent), 2018 - 2021
  • Table-02: Global - Forecast for Cardiac Bio Implant Devices Market Share by Type (Percent), 2022 - 2027
  • Table-03: Global - Cardiac Bio Implant Devices Market Share by Application (Percent), 2018 - 2021
  • Table-04: Global - Forecast for Cardiac Bio Implant Devices Market Share by Application (Percent), 2022 - 2027
  • Table-05: Global - Cardiac Bio Implant Devices Market Share by End-User (Percent), 2018 - 2021
  • Table-06: Global - Forecast for Cardiac Bio Implant Devices Market Share by End-User (Percent), 2022 - 2027
  • Table-07: Global - Cardiac Bio Implant Devices Market Share by Region (Percent), 2018 - 2021
  • Table-08: Global - Forecast for Cardiac Bio Implant Devices Market Share by Region (Percent), 2022 - 2027
目次

Global Cardiac Bio Implant Devices Market is anticipated to reach US$ 51.21 Billion in 2028. Over the years, high cholesterol, smoking, and high blood pressure has been linked to cardiac illness. Other conditions, such as diabetes and obesity and lifestyle changes such as poor nutrition, excessive alcohol use, and physical inactivity, have been increasing the risk of cardiac disease. Hence, Cardiac Bio Implant Devices are electronic ormechanical implantable devices developed to aid in the treatment of cardiac disorders. Long-term cardiac problems, such as heart failure and other heart dysfunctions, are treated with these devices. Furthermore, the second stage of cardiac treatment involves implanting devices inside the patient's body.

Worldwide Cardiac Bio Implant Devices Industry will grow at a CAGR of 7.3% from 2021-2028

The increasing prevalence and awareness of cardiovascular disorders drive the Global Cardiac Bio Implant Devices Market. Furthermore, non-communicable diseases such as diabetes, hypertension, obesity, and others are causing a significant increase in new cases in developed countries. In contrast, lifestyle disorders such as smoking and alcoholism put developing countries with limited healthcare infrastructure at risk. As a result of their increased sensitivity to heart failure, the populations impacted by these illnesses will be a significant driver of demand in the coming years.

CRT (Cardiac Resynchronization Therapy) Is Determined to Be the Most Effective:

In our analysis, the market has been categorized into Pacemaker, ICDs (Implantable Cardioverter Defibrillator), and CRTs (Cardiac Resynchronization Therapy). According to our calculations, the CRT (Cardiac Resynchronization Therapy) market will be dominating in 2021 and throughout the study period. CRT is a clinically validated therapeutic option for some people with heart failure. Furthermore, the CRT device transmits mild electrical impulses to both heart's lower chambers to help them beat in a more coordinated way. Additionally, the heart's ability to pump blood and oxygen throughout the body is expected to improve.

Impacts of the COVID-19 Pandemic on Cardiac Bio-Implant Industry:

Most sectors throughout the world have been significantly impacted due to significant disruptions to their manufacturing and supply-chain operations due to various precautionary lockdowns and other limitations imposed by regulatory authorities around the world. The global Cardiac Bio Implant Devices market is no exception. As the prevailing economic condition of most people was adversely affected by the outbreak, consumer demand was reduced as people were keener on removing non-essential expenses from their separate budgets. However, the global Cardiac Bio Implant Devices market recovered as different government authorities began to break the enforced lockdowns in 2020. According to Renub Research report, The Global Cardiac Bio Implant Devices Market Size was US$ 31.29 Billion in 2021.

Throughout The Study Period, Myocardial Ischemia Continues to Be the Leading Cause of Death:

In our report, By Applications, the Global Cardiac Bio Implant Devices Market is divided into Arrhythmias, Myocardial Ischemia, Acute Myocardial Infarction, and Heart Failure. According to our findings, Myocardial Ischemia continues to be the leading cause of death during the study period. A condition known as myocardial ischemia occurs when the heart muscles do not receive enough blood. It could be because of a deficiency of oxygenated blood in this area or blockages in the coronary arteries, the leading supplier of these nutrients and oxygen. Myocardial Ischemia has several advantages, including preventing sudden death from strokes and a decrease in mortality rates among individuals with heart disease.

Regional Realms of the Global Cardiac Bio Implant Devices Market:

During the projection period of 2021-2028, Asia-Pacific is expected to dominate the market and increase steadily. The high prevalence of chronic diseases, combined with rising disposable income, has resulted in a higher acceptance rate for medical treatments such as implants, among other things, across the globe, especially in India and China. Similarly, the European market is expected to rise steadily, owing to an increase in the senior population and the increased prevalence of the cardiovascular disease. Furthermore, many cardiac implant device manufacturers in Europe have resulted in severe competition between them in terms of production costs while also ensuring that quality standards are maintained.

Key Players in the Market:

Our report examines the Global Cardiac Bio Implant Devices Market in-depth, outlining its competitive landscape, potential growth opportunities, and potential pitfalls, as well as providing information on market participants such as Agilent Technologies, Eurofins Scientific, F. Hoffman-La Roche, Illumina, Inc., Natera, Inc., PerkinElmer Inc., Quest Diagnostics, and Thermo Fisher Scientific. Key players are more engaged with launching techniques such as focused marketing and CSR activities to enhance worldwide significance.

Renub Research latest report "Cardiac Bio Implant Devices Market, Global Forecast By Type (Pacemaker, ICDs (Implantable Cardioverter Defibrillator), CRT (Cardiac Resynchronization Therapy), Application (Arrhythmias, Myocardial Ischemia, Acute Myocardial Infarction, Heart Failure), End-User (Hospitals, Cardiac Care Centers, Ambulatory Centers & Home Care, Academic Institutes, Others), Region (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, Companies (Agilent Technologies, Eurofins Scientific, F. Hoffman-La Roche, Illumina, Inc., Natera, Inc., PerkinElmer Inc., Quest Diagnostics, and Thermo Fisher Scientific)" provides a detailed analysis of Cardiac Bio Implant Devices Industry.

Type - Market have been covered from 3 viewpoints:

  • 1. Pacemaker
  • 2. ICDs (Implantable Cardioverter Defibrillator)
  • 3. CRT (Cardiac Resynchronization Therapy)

Application - Market have been covered from 4 viewpoints:

  • 1. Arrhythmias
  • 2. Myocardial Ischemia
  • 3. Acute Myocardial Infarction
  • 4. Heart Failure

End-User - Market have been covered from 4 viewpoints:

  • 1. Hospitals
  • 2. Cardiac Care Centers
  • 3. Ambulatory Centers & Home Care
  • 4. Academic Institutes
  • 5. Others

Region - Market have been covered from 5 viewpoints:

  • 1. North America
  • 2. Europe
  • 3. Asia-Pacific
  • 4. Latin America
  • 5. Middle East and Africa

Company Insights:

  • Overview
  • Recent Development & Strategies
  • Revenue Analysis

Companies Covered:

  • 1. Agilent Technologies
  • 2. Eurofins Scientific
  • 3. F. Hoffman-La Roche
  • 4. Illumina, Inc.
  • 5. Natera, Inc.
  • 6. PerkinElmer Inc.
  • 7. Quest Diagnostics
  • 8. Thermo Fisher Scientific

Table of Contents

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Dynamics

  • 4.1 Growth Drivers
  • 4.2 Challenges

5. Cardiac Bio Implant Devices Market

6. Market Share - Cardiac Bio Implant Devices Market

  • 6.1 By Type
  • 6.2 By Application
  • 6.3 By End-User
  • 6.4 By Region

7. Type - Cardiac Bio Implant Devices Market

  • 7.1 Pacemaker
  • 7.2 ICDs (Implantable Cardioverter Defibrillator)
  • 7.3 CRT (Cardiac Resynchronization Therapy)

8. Application - Cardiac Bio Implant Devices Market

  • 8.1 Arrhythmias
  • 8.2 Myocardial Ischemia
  • 8.3 Acute Myocardial Infarction
  • 8.4 Heart Failure

9. End-User - Cardiac Bio Implant Devices Market

  • 9.1 Hospitals
  • 9.2 Cardiac Care Centers
  • 9.3 Ambulatory Centers & Home Care
  • 9.4 Academic Institutes
  • 9.5 Others

10. Region - Cardiac Bio Implant Devices Market

  • 10.1 North America
  • 10.2 Europe
  • 10.3 Asia-Pacific
  • 10.4 Latin America
  • 10.5 Middle East and Africa

11. Porters Five Forces

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12. Company Analysis

  • 12.1 Agilent Technologies
    • 12.1.1 Overview
    • 12.1.2 Recent Development
    • 12.1.3 Revenue Analysis
  • 12.2 Eurofins Scientific
    • 12.2.1 Overview
    • 12.2.2 Recent Development
    • 12.2.3 Revenue Analysis
  • 12.3 F. Hoffman-La Roche
    • 12.3.1 Overview
    • 12.3.2 Recent Development
    • 12.3.3 Revenue Analysis
  • 12.4 Illumina, Inc.
    • 12.4.1 Overview
    • 12.4.2 Recent Development
    • 12.4.3 Revenue Analysis
  • 12.5 Natera, Inc.
    • 12.5.1 Overview
    • 12.5.2 Recent Development
    • 12.5.3 Revenue Analysis
  • 12.6 PerkinElmer Inc.
    • 12.6.1 Overview
    • 12.6.2 Recent Development
    • 12.6.3 Revenue Analysis
  • 12.7 Quest Diagnostics
    • 12.7.1 Overview
    • 12.7.2 Recent Development
    • 12.7.3 Revenue Analysis
  • 12.8 Thermo Fisher Scientific
    • 12.8.1 Overview
    • 12.8.2 Recent Development
    • 12.8.3 Revenue Analysis